These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5837540)

  • 1. [Effects of 1-4-dihydrazinophthalazine on arterial circulation of the limbs in normal and artery disease patients].
    Leoni E
    Gazz Int Med Chir; 1965 Sep; 69(17):1468-74. PubMed ID: 5837540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peripheral arterial disease--in the field of internal medicine].
    Seki K
    Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thrombolytic treatment of chronic arterial obstruction].
    Mazák J; Bláha M; Vodicková L; Pidrman V
    Vnitr Lek; 1974 Jul; 20(6):596-602. PubMed ID: 4844794
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K; Sato K; Tanaka S
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
    Chrzanowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
    Savel'ev IuS
    Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
    Zhang GS
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
    [No Abstract]   [Full Text] [Related]  

  • 19. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of bencyclane in arterial insufficiency of the lower limbs].
    Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.